Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Research ArticleBasic Science Investigations

Whole-Body Distribution and Radiation Dosimetry of 11C-(+)-PHNO, a D2/3 Agonist Ligand

Romina Mizrahi, Pablo Rusjan, Irina Vitcu, Alvina Ng, Alan A. Wilson, Sylvain Houle and Peter M. Bloomfield
Journal of Nuclear Medicine November 2012, 53 (11) 1802-1806; DOI: https://doi.org/10.2967/jnumed.112.105627
Romina Mizrahi
Centre for Addiction and Mental Health, Toronto, Ontario, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Pablo Rusjan
Centre for Addiction and Mental Health, Toronto, Ontario, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Irina Vitcu
Centre for Addiction and Mental Health, Toronto, Ontario, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Alvina Ng
Centre for Addiction and Mental Health, Toronto, Ontario, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Alan A. Wilson
Centre for Addiction and Mental Health, Toronto, Ontario, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sylvain Houle
Centre for Addiction and Mental Health, Toronto, Ontario, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Peter M. Bloomfield
Centre for Addiction and Mental Health, Toronto, Ontario, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Article Figures & Data

Figures

  • Tables
  • FIGURE 1.
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIGURE 1.

    11C-(+)-PHNO whole-body biodistribution over time for typical subject. PET (color scale) images are coregistered with subjects’ CT image (gray scale). Time, in seconds, above each image is acquisition start time after injection of first bed position of whole-body image, whereas time, also in seconds, below each image is duration of each bed position in whole-body image. Image sequence is not decay-corrected to injection time; decay correction is applied only when each whole-body image is created from its individual-bed-position images.

  • FIGURE 2.
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIGURE 2.

    Mean organ uptake (expressed as percentage of injected dose) for all 6 subjects over time. Vertical bars represent SD, and data are not decay-corrected to time 0.

Tables

  • Figures
    • View popup
    TABLE 1

    Normalized Accumulated Activity Measured Assuming Organ Volume for Standard Male and Female

    OrganAll subjects (n = 6) as malesFemales (n = 3) as females
    Whole brain0.027 ± 0.0070.029 ± 0.005
    Lung0.027 ± 0.0090.027 ± 0.007
    Liver0.102 ± 0.0240.073 ± 0.011
    Spleen0.003 ± 0.0010.003 ± 0.000
    Kidneys0.014 ± 0.0040.014 ± 0.005
    Bladder0.017 ± 0.0050.011 ± 0.003
    Remainder0.300 ± 0.0250.333 ± 0.009
    • Data are organ MBq⋅h divided by injected MBq (mean ± SD).

    • View popup
    TABLE 2

    Organ Dose as Calculated by OLINDA/EXM 1.1 for Standard Adult Hermaphrodite Male Model as Applied to All 6 Subjects and Standard Female Model as Applied Only to the 3 Female Subjects

    ParameterSAHMMSAFM
    Organ dose (μGy/MBq)
     Adrenals3.5 ± 0.14.3 ± 0.1
     Brain6.4 ± 1.78.2 ± 1.2
     Breasts2.0 ± 0.12.6 ± 0.0
     Gallbladder wall4.4 ± 0.44.8 ± 0.2
     Lower large intestine wall2.4 ± 0.23.2 ± 0.1
     Small intestine2.6 ± 0.13.2 ± 0.1
     Stomach wall2.6 ± 0.13.4 ± 0.0
     Upper large intestine wall2.7 ± 0.13.5 ± 0.1
     Heart wall2.9 ± 0.03.7 ± 0.1
     Kidneys14.3 ± 3.615.8 ± 4.5
     Liver17.9 ± 3.917.4 ± 2.4
     Lungs8.2 ± 2.210.1 ± 2.3
     Muscle2.2 ± 0.12.9 ± 0.1
     Ovaries2.5 ± 0.23.3 ± 0.1
     Pancreas3.4 ± 0.14.2 ± 0.1
     Red marrow2.1 ± 0.12.7 ± 0.0
     Osteogenic cells3.1 ± 0.24.4 ± 0.1
     Skin1.7 ± 0.12.3 ± 0.0
     Spleen6.4 ± 0.87.6 ± 0.5
     Testes2.0 ± 0.1—
     Thymus2.2 ± 0.13.1 ± 0.1
     Thyroid2.1 ± 0.12.6 ± 0.1
     Urinary bladder wall13.5 ± 3.712.8 ± 3.2
     Uterus2.8 ± 0.23.5 ± 0.2
     Total body2.9 ± 0.03.6 ± 0.0
    Effective dose (μSv/MBq)
     Effective dose equivalent5.8 ± 0.46.7 ± 0.2
     Effective dose4.5 ± 0.35.2 ± 0.2
    • SAHMM = standard adult hermaphrodite male model; SAFM = standard female model.

PreviousNext
Back to top

In this issue

Journal of Nuclear Medicine: 53 (11)
Journal of Nuclear Medicine
Vol. 53, Issue 11
November 1, 2012
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Whole-Body Distribution and Radiation Dosimetry of 11C-(+)-PHNO, a D2/3 Agonist Ligand
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
Whole-Body Distribution and Radiation Dosimetry of 11C-(+)-PHNO, a D2/3 Agonist Ligand
Romina Mizrahi, Pablo Rusjan, Irina Vitcu, Alvina Ng, Alan A. Wilson, Sylvain Houle, Peter M. Bloomfield
Journal of Nuclear Medicine Nov 2012, 53 (11) 1802-1806; DOI: 10.2967/jnumed.112.105627

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Whole-Body Distribution and Radiation Dosimetry of 11C-(+)-PHNO, a D2/3 Agonist Ligand
Romina Mizrahi, Pablo Rusjan, Irina Vitcu, Alvina Ng, Alan A. Wilson, Sylvain Houle, Peter M. Bloomfield
Journal of Nuclear Medicine Nov 2012, 53 (11) 1802-1806; DOI: 10.2967/jnumed.112.105627
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
    • Abstract
    • MATERIALS AND METHODS
    • RESULTS
    • DISCUSSION
    • CONCLUSION
    • DISCLOSURE STATEMENT
    • Acknowledgments
    • Footnotes
    • REFERENCES
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

  • This Month in JNM
  • PubMed
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • PET/MRI of Hypoxic Atherosclerosis Using 64Cu-ATSM in a Rabbit Model
  • Tumor Uptake of Anti-CD20 Fabs Depends on Tumor Perfusion
  • How Sensitive Is the Upper Gastrointestinal Tract to 90Y Radioembolization? A Histologic and Dosimetric Analysis in a Porcine Model
Show more Basic Science Investigations

Similar Articles

Keywords

  • biodistribution
  • dosimetry
  • Positron Emission Tomography
  • [11C]-(+)-PHNO
  • D2
  • D3
SNMMI

© 2025 SNMMI

Powered by HighWire